Agnes C Kant

机构：Leiden University, Leiden University Medical Center, Netherlands Pharmacovigilance Centre Lareb · ORCID：0000-0003-3767-110X

发表论文 102 篇 · 总被引 3219 次 · h-index 23

代表论文

• Faecal carriage, risk factors, acquisition and persistence of ESBL-producing Enterobacteriaceae in dogs and cats and co-carriage with humans belonging to the same household (2019 · Journal of Antimicrobial Chemotherapy · 被引 94)
• Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands (2022 · Drug Safety · 被引 58)
• Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature (2023 · Frontiers in Immunology · 被引 48)
• COVID-19 vaccine reactogenicity – A cohort event monitoring study in the Netherlands using patient reported outcomes (2022 · Vaccine · 被引 45)
• Aim and Design of pREGnant, the Dutch Pregnancy Drug Register (2018 · Drug Safety · 被引 28)
• Numbers of spontaneous reports: How to use and interpret? (2021 · British Journal of Clinical Pharmacology · 被引 24)